Started by Stellar, December 13, 2020, 01:27:21 AM
0 Members and 1 Guest are viewing this topic.
QuoteIn this study, we designed three mRNA vaccine candidates for COVID-19, and they encode various forms of antigens in vaccinated hosts (Fig. 1a). RQ3011-RBD encodes the receptor-binding domain of the S (spike) glycoprotein (residues 331â€"524) of SARS-CoV-2 with an N-terminal signal peptide and a C-terminal membrane-anchoring helix. https://www.nature.com/articles/s41422-020-00392-7